BioLinker secures R$8.4 million for automated laboratory in Manaus
The package includes funding from an Axcell-managed vehicle and a PIPE/FAPESP grant.
BioLinker disclosed R$8.4 million in financing on October 6: R$7.2 million from an Axcell-managed fund and R$1.2 million through FAPESP’s PIPE Phase 2 programme. The round remains open.
The company will build an automated laboratory at the Amazon BioBusiness Center in Manaus, expand DNA production and generate data for AI development. It also plans to grow its team as production capacity increases.
Use of funds
Automated Manaus laboratory
DNA production
Biological data generation